Onco Therapies Limited (OTL), the wholly-owned oncology subsidiary of Strides, has received the UK's approval for Oxaliplatin injections in strengths of 5 mg per 10 ml, 5 mg per 20 ml and 5 mg per 40 ml, Strides Arcolab said in a statement.
"The current approval is from UK and approval for the rest of the European countries is expected shortly," it added.
4800
0
1889
3499
8800
10000
229
595
328
596
1424
2499
389
940
430
999
1290
2999
470
999
13550
27099
1200
2499
1388
1850